Protection from DNBS-induced colitis by the tachykinin NK1 receptor antagonist SR140333 in rats

European Journal of Pharmacology

Volumn 603, Issue 1-3, 2009, Pages 133-137

  Ursino, Maria Grazia ^a   Vasina, Valentina ^a   De Ponti, Fabrizio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Animal model; Inflammatory bowel disease; Substance P; Tachykinin receptor

Indexed keywords

2,4 DINITROBENZENE SULFONIC ACID; MYELOPEROXIDASE; NEUROKININ 1 RECEPTOR; NOLPITANTIUM; SUBSTANCE P; SULFONIC ACID DERIVATIVE; TACHYKININ; TACHYKININ RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLITIS; COLON INJURY; CONTROLLED STUDY; ENTERITIS; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; HISTOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WEIGHT GAIN;

ANIMALS; COLITIS; DINITROFLUOROBENZENE; HUMANS; INFLAMMATION; INTESTINES; MALE; PIPERIDINES; QUINUCLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TACHYKININ; SUBSTANCE P; SUBSTRATE SPECIFICITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58249101397     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.11.064     Document Type: Article

References (33)

1. Azzolina A., Bongiovanni A., and Lampiasi N. Substance P induces TNF-alpha and IL-6 production through NF kappa B in peritoneal mast cells. Biochim. Biophys. Acta 1643 (2003) 75-83
2. Blandizzi C., Fornai M., Colucci R., Baschiera F., Barbara G., De Giorgio R., De Ponti F., Breschi M.C., and Del Tacca M. Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis. Br. J. Pharmacol. 139 (2003) 309-320
3. Boughton-Smith N.K., Wallace J.L., and Whittle B.J. Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 25 (1988) 115-123
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
5. Castagliuolo I., Keates A.C., Qiu B., Kelly C.P., Nikulasson S., Leeman S.E., and Pothoulakis C. Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 4788-4793
6. Crema F., Moro E., Nardelli G., De Ponti F., Frigo G., and Crema A. Role of tachykininergic and cholinergic pathways in modulating canine gastric tone and compliance in vivo. Pharmacol. Res. 45 (2002) 341-347
7. De Giorgio R., Barbara G., Blennerhassett P., Wang L., Stanghellini V., Corinaldesi R., Collins S.M., and Tougas G. Intestinal inflammation and activation of sensory nerve pathways: a functional and morphological study in the nematode infected rat. Gut 49 (2001) 822-827
8. Di Sebastiano P., Grossi L., Di Mola F.F., Angelucci D., Friess H., Marzio L., Innocenti P., and Buchler M.W. SR140333, a substance P receptor antagonist, influences morphological and motor changes in rat experimental colitis. Dig. Dis. Sci. 44 (1999) 439-444
9. Elson C.O., Sartor R.B., Tennyson G.S., and Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology 109 (1995) 1344-1367
10. Emonds-Alt X., Doutremepuich J.D., Heaulme M., Neliat G., Santucci V., Steinberg R., Vilain P., Bichon D., Ducoux J.P., Proietto V., Broeck D.V., Soubriè P., Le Fur G., and Brelière J.C. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur. J. Pharmacol. 250 (1993) 403-413
11. Emonds-Alt X., Doutremepuich J.D., Jung M., Proietto E., Santucci V., Van Broeck D., Vilain P., Soubriè P., Le Fur, and Brelière J.C. SR 140333, a non-peptide antagonist of substance-P (NK1) receptor. Neuropeptides 24 (1993) 231-239
12. Eysselein V.E., Reinshagen M., Cominelli F., Sternini C., Davis W., Patel A., Nast C.C., Bernstein D., Anderson K., and Khan H. Calcitonin gene-related peptide and substance P decrease in the rabbit colon during colitis. A time study. Gastroenterology 101 (1991) 1211-1219
13. Faussone-Pellegrini M.S. Relationships between neurokinin receptor-expressing interstitial cells of Cajal and tachykininergic nerves in the gut. J. Cell. Mol. Med. 10 (2006) 20-32
14. Goode T., O'Connell J., Anton P., Wong H., Reeve J., O'Sullivan G.C., Collins J.K., and Shanahan F. Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation. Gut 47 (2000) 387-396
15. Gross K.J., and Pothoulakis C. Role of neuropeptides in inflammatory bowel disease. Inflamm. Bowel Dis. 13 (2007) 918-932
16. Ho W.Z., Lai J.P., Zhu X.H., Uvaydova M., and Douglas S.D. Human monocytes and macrophages express substance P and neurokinin-1 receptor. J. Immunol. 159 (1997) 5654-5660
17. Holzer P., and Holzer-Petsche U. Tachykinin receptors in the gut: physiological and pathological implications. Curr. Opin. Pharmacol. 1 (2001) 583-590
18. Lai J.P., Douglas S.D., and Ho W.Z. Human lymphocytes express substance P and its receptor. J. Neuroimmunol. 86 (1998) 80-86
19. Mantyh C.R., Pappas T.N., Lapp J.A., Washington M.K., Neville L.M., Ghilardi J.R., Rogers S.D., Mantyh P.W., and Vigna S.R. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum. Gastroenterology 111 (1996) 1272-1280
20. Mazelin L., Theodorou V., More J., Emonds-Alt X., Fioramonti J., and Bueno L. Comparative effects of nonpeptide tachykinin receptor antagonists on experimental gut inflammation in rats and guinea-pigs. Life Sci. 63 (1998) 293-304
21. Metwali A., Blum A.M., Elliott D.E., Setiawan T., and Weinstock J.V. Cutting edge: hemokinin has substance P-like function and expression in inflammation. J. Immunol. 172 (2004) 6528-6532
22. Miampamba M., and Sharkey K.A. Distribution of calcitonin gene-related peptide, somatostatin, substance P and vasoactive intestinal polypeptide in experimental colitis in rats. Neurogastroenterol. Motil. 10 (1998) 315-329
23. Miller M.J., Sadowska-Krowicka H., Jeng A.Y., Chotinaruemol S., Wong M., Clark D.A., Ho W., and Sharkey K.A. Substance P levels in experimental ileitis in guinea pigs: effects of misoprostol. Am. J. Physiol. 265 (1993) G321-G330
24. Morteau O., Lu B., Gerard C., and Gerard N.P. Hemokinin 1 is a full agonist at the substance P receptor. Nat. Immunol. 2 (2001) 1088
25. Pothoulakis C., Castagliuolo I., LaMont J.T., Jaffer A., O'Keane J.C., Snider R.M., and Leeman S.E. CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 947-951
26. Rijnierse A., van Zijl K.M., Koster A.S., Nijkamp F.P., and Kraneveld A.D. Beneficial effect of tachykinin NK1 receptor antagonism in the development of hapten-induced colitis in mice. Eur. J. Pharmacol. 548 (2006) 150-157
27. Simeonidis S., Castagliuolo I., Pan A., Liu J., Wang C.C., Mykoniatis A., Pasha A., Valenick L., Sougioultzis S., Zhao D., and Pothoulakis C. Regulation of the NK-1 receptor gene expression in human macrophage cells via an NF-kappa B site on its promoter. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 2957-2962
28. Simpson J., Sundler F., Humes D.J., Jenkins D., Wakelin D., Scholefield J.H., and Spiller R.C. Prolonged elevation of galanin and tachykinin expression in mucosal and myenteric enteric nerves in trinitrobenzene sulphonic acid colitis. Neurogastroenterol. Motil. 20 (2008) 392-406
29. Stucchi A.F., Shofer S., Leeman S., Materne O., Beer E., McClung J., Shebani K., Moore F., O'Brien M., and Becker J.M. NK-1 antagonist reduces colonic inflammation and oxidative stress in dextran sulfate-induced colitis in rats. Am. J. Physiol.: Gasterointest. Liver Physiol. 279 (2000) G1298-G1306
30. Sturiale S., Barbara G., Qiu B., Figini M., Geppetti P., Gerard N., Gerard C., Grady E.F., Bunnett N.W., and Collins S.M. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 11653-11658
31. Vasina V., Abu-Gharbieh E., Barbara G., De Giorgio R., Colucci R., Blandizzi C., Bernardini N., Croci T., Del Tacca M., and De Ponti F. The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats. Neurogastroenterol. Motil. 20 (2008) 1030-1041
32. Wallace J.L., Le T., Carter L., Appleyard C.B., and Beck P.L. Hapten-induced chronic colitis in the rat: alternatives to trinitrobenzene sulfonic acid. J. Pharmacol. Toxicol. Methods 33 (1995) 237-239
33. Zhang Y., Lu L., Furlonger C., Wu G.E., and Paige C.J. Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis. Nat. Immunol. 1 (2000) 392-397